these findings could be accounted for by one of three possible mechanisms : ( a ) an inherited recessive gene ( anti-oncogene or tumor suppressor gene ) in this region of 3p was uncovered by the combined modality therapy , ( b ) an inherited predisposition to damage of both chromosomes at 3p14 leads to sclc and erythroleukemia after exposure to carcinogens and/or chemotherapy-radiotherapy , or ( c ) the finding of lineage specificity for the 3p deletion with the presence of the 3p deletion in sclc and erythroleukemia suggests a common bone marrow precursor .
C0023440
erythroleukemia
C0005953
bone marrow